LAMEA Medical Software Market By Delivery mode (On Premises, Cloud and Web Based), Software Service (Client Relationship Management, Electronic Health Records, Medical Practice Management, Telemedicine, Population Health Management, Others), and End User (Healthcare Providers, Healthcare Payers, Others): Global Opportunity Analysis and Industry Forecast, 2024-2033

March 2024 | 170 pages | ID: L41B6A8F734BEN
Allied Market Research

Abstracts

The LAMEA medical software market was valued for $11,283.18 million in 2023 and is estimated t%li%reach $ 30,843.6 million by 2033, exhibiting a CAGR of 10.6% from 2024 t%li%2033.Medical software refers t%li%specialized computer programs and applications designed for healthcare purposes. Its wide applications span various aspects of healthcare, including electronic health records (EHR) for efficient patient data management, telehealth solutions facilitating remote patient care, and aid healthcare professionals in decision-making. Medical software als%li%includes tools for medical claim management, ensuring accurate financial transactions. Furthermore, it plays a crucial role in population health management, offering insights int%li%large datasets t%li%enhance preventive care. The applications of medical software contribute t%li%improved patient outcomes, streamlined healthcare workflows, and the overall efficiency of healthcare delivery.?The factor that drives the medical software market growth includes the increasing adoption of healthcare information technology (IT). Healthcare IT encompasses a broad range of technologies, including electronic health records (EHR), health information exchange (HIE) platforms, telehealth solutions, and other digital tools designed t%li%improve the efficiency and effectiveness of healthcare delivery. The adoption of these technologies is driven by the recognition of their potential t%li%enhance patient care, streamline administrative processes, and facilitate better communication and collaboration among healthcare professionals.?Healthcare IT adoption is particularly crucial in the pursuit of improved patient outcomes and comprehensive care. Electronic health records, for instance, enable seamless and secure storage and retrieval of patient information, reducing the likelihood of errors and providing a holistic view of a patient's medical history. Thus, health information exchange platforms allow for interoperability, enabling different healthcare entities t%li%share crucial patient data, leading t%li%more coordinated and informed decision-making.?Simultaneously, the growing focus on cost reduction within the healthcare industry serves as another driver for the medical software market. Healthcare providers are under increasing pressure t%li%optimize operational efficiency and reduce overall expenditures while maintaining or improving the quality of patient care. Medical software solutions contribute t%li%cost reduction by automating administrative tasks, streamlining workflows, and minimizing errors in documentation processes. Efficient use of medical software can lead t%li%time and resource savings, allowing healthcare organizations t%li%allocate resources more effectively.?For instance, telemedicine solutions, a subset of medical software, play a crucial role in cost reduction by enabling remote consultations and monitoring, potentially reducing the need for in-person visits and associated overhead costs. Additionally, the implementation of data analytics tools within medical software allows healthcare organizations t%li%identify areas for improvement, optimize resource utilization, and implement evidence-based practices, all of which contribute t%li%long-term cost reduction strategies. Thus, the growing focus on cost reduction is further contributing t%li%the market growth.???The LAMEA medical software market is segmented on the basis of delivery mode, software service, end user, and country. According t%li%delivery mode, the market is categorized int%li%on-premises and web & cloud-based. On the basis of software service, it is segmented int%li%client relationship management (CRM), electronic health records (EHR), medical practice management, telemedicine, population health management and others. On the basis of end user, it is segmented int%li%healthcare providers, healthcare payers and others. Furthermore, LAMEA region is studied across Brazil, Saudi Arabia, South Africa, and Rest of LAMEA.???The major companies profiled in the report include Veradigm LLC, Oracle Corporation, GE Healthcare, EPIC Systems Corporation, Meditech, Koninklijke Philips N.V., Dedalus S.P.A., Health Catalyst, Inc, UnitedHealth Group (Optum, Inc), and Teladoc Health, Inc. The key players have adopted various strategies such as product launch, collaboration, agreement, partnership and others t%li%enhance their product portfolio.KEY BENEFITS FOR STAKEHOLDERSь The study provides an in-depth analysis of the LAMEA medical software and the current trends and future estimations t%li%elucidate the imminent investment pockets.ь It presents a quantitative analysis of the market from 2022 t%li%2032 t%li%enable stakeholders t%li%capitalize on the prevailing market opportunities.ь Porter's five forces analysis illustrates the potency of buyers and suppliers operating in the industry.ь Key players and their strategies are thoroughly analyzed t%li%understand the competitive outlook of the market.

KEY MARKET SEGMENT

By Delivery mode

• On-premises
• Web & cloud-based

By Software service

• Client Relationship Management (CRM)
• Electronic Health Records (EHR)
• Medical Practice Management
• Telemedicine
• Population Health Management
• Others

By End user

• Healthcare providers
• Healthcare payers
• Others

By Country

• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

• Veradigm LLC
• Oracle Corporation
• GE Healthcare
• EPIC Systems Corporation
• MEDITECH
• Koninklijke Philips N.V.
• Dedalus S.P.A.
• Health Catalyst, Inc.
• UnitedHealth Group (Optum, Inc.)
• Teladoc Health, Inc.

Contents

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits
1.4.Research methodology
  1.4.1.Primary research
  1.4.2.Secondary research
  1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
  3.2.1.Top Impacting factors
  3.2.2.Top investment pockets
3.3.Porter’s five forces analysis
  3.3.1.Bargaining power of suppliers
  3.3.2.Bargaining power of buyers
  3.3.3.Threat of substitution
  3.3.4.Threat of new entrants
  3.3.5.Intensity of competitive rivalry
3.4.Market Dynamics
  3.4.1.Drivers
    3.4.1.1.Increasing adoption of electronic health records (EHR)
    3.4.1.2.Technological advancements in software development
    3.4.1.3.Rise in strategic initiatives among the key players
  3.4.2.Restraints
    3.4.2.1.Data security concerns
  3.4.3.Opportunities
    3.4.3.1.Growing focus on digital transformation
3.5.Recession Impact Analysis

CHAPTER 4:LAMEA MEDICAL SOFTWARE MARKET, BY DELIVERY MODE

4.1.Market overview
  4.1.1.Market size and forecast
4.2.On premises
  4.2.1.Key market trends, growth factors and opportunities
  4.2.2.Market size and forecast, by region
  4.2.3.Market share analysis, by country
4.3.Cloud and web based
  4.3.1.Key market trends, growth factors and opportunities
  4.3.2.Market size and forecast, by region
  4.3.3.Market share analysis, by country

CHAPTER 5:LAMEA MEDICAL SOFTWARE MARKET, BY SOFTWARE SERVICE

5.1.Market overview
  5.1.1.Market size and forecast
5.2.Client relationship management
  5.2.1.Market size and forecast, by region
  5.2.2.Market share analysis, by country
5.3.Electronic health records
  5.3.1.Market size and forecast, by region
  5.3.2.Market share analysis, by country
5.4.Medical practice management
  5.4.1.Market size and forecast, by region
  5.4.2.Market share analysis, by country
5.5.Telemedicine
  5.5.1.Market size and forecast, by region
  5.5.2.Market share analysis, by country
5.6.Population health management
  5.6.1.Market size and forecast, by region
  5.6.2.Market share analysis, by country
5.7.Others
  5.7.1.Market size and forecast, by region
  5.7.2.Market share analysis, by country

CHAPTER 6:LAMEA MEDICAL SOFTWARE MARKET, BY END USER

6.1.Market overview
  6.1.1.Market size and forecast
6.2.Healthcare providers
  6.2.1.Market size and forecast, by region
  6.2.2.Market share analysis, by country
6.3.Healthcare payers
  6.3.1.Market size and forecast, by region
  6.3.2.Market share analysis, by country
6.4.Others
  6.4.1.Market size and forecast, by region
  6.4.2.Market share analysis, by country

CHAPTER 7:LAMEA MEDICAL SOFTWARE MARKET, BY REGION

7.1.Market overview
  7.1.1.Market size and forecast, by region
7.2.LAMEA
  7.2.1.Key market trends, growth factors, and opportunities
  7.2.2.Market size and forecast, by delivery mode
  7.2.3.Market size and forecast, by software service
  7.2.4.Market size and forecast, by end user
  7.2.5.LAMEA Market size and forecast, by country
    7.2.5.1.Brazil
      7.2.5.1.1.Market size and forecast, by delivery mode
      7.2.5.1.2.Market size and forecast, by software service
      7.2.5.1.3.Market size and forecast, by end user
    7.2.5.2.Saudi Arabia
      7.2.5.2.1.Market size and forecast, by delivery mode
      7.2.5.2.2.Market size and forecast, by software service
      7.2.5.2.3.Market size and forecast, by end user
    7.2.5.3.South Africa
      7.2.5.3.1.Market size and forecast, by delivery mode
      7.2.5.3.2.Market size and forecast, by software service
      7.2.5.3.3.Market size and forecast, by end user
    7.2.5.4.Rest of LAMEA
      7.2.5.4.1.Market size and forecast, by delivery mode
      7.2.5.4.2.Market size and forecast, by software service
      7.2.5.4.3.Market size and forecast, by end user

CHAPTER 8:COMPETITIVE LANDSCAPE

8.1.Introduction
8.2.Top winning strategies
  8.2.1.Top winning strategies, by year, 2021-2023
  8.2.2.Top winning strategies, by development, 2021-2023(%)
  8.2.3.Top winning strategies, by company, 2021-2023
8.3.Product mapping of top 10 player
8.4.Competitive dashboard
8.5.Competitive heatmap
8.6.Top player positioning

CHAPTER 9:COMPANY PROFILES

9.1.VERADIGM LLC
  9.1.1.Company overview
  9.1.2.Key executives
  9.1.3.Company snapshot
  9.1.4.Operating business segments
  9.1.5.Product portfolio
  9.1.6.Business Performance
  9.1.7.Key strategic moves and developments
9.2.ORACLE CORPORATION
  9.2.1.Company overview
  9.2.2.Key executives
  9.2.3.Company snapshot
  9.2.4.Operating business segments
  9.2.5.Product portfolio
  9.2.6.Business Performance
  9.2.7.Key strategic moves and developments
9.3.EPIC SYSTEMS CORPORATION
  9.3.1.Company overview
  9.3.2.Key executives
  9.3.3.Company snapshot
  9.3.4.Operating business segments
  9.3.5.Product portfolio
  9.3.6.Key strategic moves and developments
9.4.MEDITECH
  9.4.1.Company overview
  9.4.2.Key executives
  9.4.3.Company snapshot
  9.4.4.Operating business segments
  9.4.5.Product portfolio
9.5.KONINKLIJKE PHILIPS N.V.
  9.5.1.Company overview
  9.5.2.Key executives
  9.5.3.Company snapshot
  9.5.4.Operating business segments
  9.5.5.Product portfolio
  9.5.6.Business Performance
  9.5.7.Key strategic moves and developments
9.6.DEDALUS S.P.A.
  9.6.1.Company overview
  9.6.2.Key executives
  9.6.3.Company snapshot
  9.6.4.Operating business segments
  9.6.5.Product portfolio
9.7.HEALTH CATALYST, INC.
  9.7.1.Company overview
  9.7.2.Key executives
  9.7.3.Company snapshot
  9.7.4.Operating business segments
  9.7.5.Product portfolio
  9.7.6.Business Performance
  9.7.7.Key strategic moves and developments
9.8.UNITEDHEALTH GROUP (OPTUM, INC)
  9.8.1.Company overview
  9.8.2.Key executives
  9.8.3.Company snapshot
  9.8.4.Operating business segments
  9.8.5.Product portfolio
  9.8.6.Business Performance
9.9.TELADOC HEALTH, INC.
  9.9.1.Company overview
  9.9.2.Key executives
  9.9.3.Company snapshot
  9.9.4.Operating business segments
  9.9.5.Product portfolio
  9.9.6.Business Performance
  9.9.7.Key strategic moves and developments
9.10.GE HEALTHCARE
  9.10.1.Company overview
  9.10.2.Key executives
  9.10.3.Company snapshot
  9.10.4.Operating business segments
  9.10.5.Product portfolio
  9.10.6.Business Performance